Earnings Season Sees Investors Sour on 'Omics Tools, MDx Firms | GenomeWeb

NEW YORK (GenomeWeb News) – As second-quarter financial reports continue to roll in, investors have been unimpressed with the results offered by many of the 'omics tools and molecular diagnostics firms that comprise the GenomeWeb Daily News Index.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A researcher argues that big prizes like the Nobel or Lasker awards send the wrong message about research.

Maria Freire, the president of the Foundation for the National Institutes of Health, discusses recent genomics-fueled advances with The Open Mind's Alexander Heffner.

Three researchers win the Nobel Prize for their efforts to develop treatments for parasitic diseases.

In PLOS this week: effect of variants linked to body shape differs by age and sex, transcriptome differences in bats with and without white-nose syndrome, and more.